Atrial Fibrillation
Conditions
Keywords
Atrial Fibrillation
Brief summary
Management strategies for AF have made many advances over the last decade but there is still a great heterogeneity in the management of AF and it remains unclear how often clinicians adhere to current guidelines. A survey of an updated AF management would enable a timely assessment of implementation of current International guidelines, allow monitoring of early management of AF when a patients is admitted in a Emergency Room (ER) and Cardiology Unit.
Detailed description
Multicentre, observational study. 200 Italian Hospitals fully representing the Italian cardiology reality in terms of geographical distribution and level of hospital technology. Data collection in ER: Data on AF and Atrial Flutter episodes in ER will be collected retrospectively by checking the records of ER without collection of any data that can allow to identify the patients. These data will be collected under the responsibility of the Cardiology Departments consecutively for 4 weeks. Data collected in Cardiology: these data will be collected under the responsibility of the Cardiology Departments for 12 weeks consecutively.
Interventions
OTHERAtrial Fibrillation
Data collection on Atrial Fibrillation
Sponsors
Heart Care Foundation
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All patients with AF, admitted to cardiology wards for an urgent or planned hospitalization. * All patients admitted in a Day Hospital regimen for treatment of AF The diagnosis of AF must be confirmed by ECG. * Signed Patient Inform Consent.
Exclusion criteria
* The qualifying episode of AF was not documented with an ECG. * Age \<18 years. * Patients with AF as a complication of an acute coronary syndrome (within 1 week from symptoms onset). * Patients with AF associated with cardiothoracic surgery (within 1 week from surgery). * Concomitant participation in other studies that can modify the diagnostic and/or therapeutic treatments. * Patients already enrolled in BLITZ-AF
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate or rhythm control strategy | Baselane study completion - average 1 week | Percentage of patients in rate or thythm control therapy |
| Number of admissions of patients with AF | Enrollemnt | Number of admissions to the ER and cardiology wards of patients with AF |
| Antithrombotic strategies | Baselane study completion - average 1 week | Rate of use of oral antithrombotic strategies |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Admission to the ER for atrial flutter | Enrollment | Number of admission to the ER for atrial flutter |
| Patients regularly followed up by the cardiology centers | 12 months | Rate of patients regularly followed up by the cardiology centers |
| Adherence to the 1A recommendations of current guidelines | 12 months | Rate of adherence to the 1A recommendations of current guidelines |
Countries
Italy
Outcome results
None listed